Barale, C
Preclinical studies in rodent models have examined its interactions with nitric oxide signaling, angiogenic factors including VEGF, fibroblast migration, and collagen synthesis in various tissue types
Liraglutide , marketed under the brand name Saxenda, is one such treatment approved for chronic weight management in individuals with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher who have at least one weight-related condition
Mechanisms and modification of chlorine-induced lung injury in animals
doi: 10.3389/fneur.2025.1663136 Received 10 July 2025 Accepted 18 August 2025 Published 02 September 2025 Volume 16 - 2025 Edited by Elvio Della Giustina, University Hospital of Modena, Italy Reviewed by Shayne Mason, North-West University, South Africa Valentina Magliocca, Bambino Ges Childrens Hospital, IRCCS, Italy Updates Copyright 2025 Tao, Huo, Hao and Liang
Detoxification Support: The liver is highly active during the night